H
$ Value
$0
Shares
20,321
Price
$0
Filed
Mar 6
Insider
Name
LINDAHL RICHARD S
Title
EVP, Chief Financial Officer
CIK
0001196632
Roles
Officer
Transaction Details
Transaction Date
2026-02-25
Code
H
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
The reported stock options expired unexercised pursuant to their terms and no value was received. | Vested in three equal installments on May 7, 2019, May 7, 2020 and May 7, 2021. | Vested in three equal installments beginning on the day prior to the first anniversary of the date of grant, subject to continued service with the company.
Filing Info
LINDAHL RICHARD S's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-05 | EBS | F | $200K |
| 2026-03-03 | EBS | A | $0 |
| 2026-03-01 | EBS | F | $6K |
| 2026-02-25 | EBS | H | $0 |
| 2026-02-06 | EBS | D | $504K |
| 2026-02-06 | EBS | F | $62K |
| 2026-01-02 | CMPX | A | $0 |
| 2025-10-15 | EBS | F | $48K |
| 2025-06-08 | EBS | F | $18K |
| 2025-05-07 | EBS | H | $0 |
Other Insiders at EBS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| FOWLER JOHN D JR | — | — | 2026-03-03 |
|
LINDAHL RICHARD S
EVP, Chief Financial Officer
|
— | — | 2026-03-05 |
|
PAPA JOSEPH C
President and CEO
|
— | — | 2026-03-05 |
|
Glessner Coleen
EVP, Quality & Ethics, and CPL
|
— | — | 2026-03-05 |
|
Williams Paul Anthony
SVP, Products Business
|
— | $34K | 2026-04-01 |
|
Hartzel William
SVP, Bioservices
|
— | — | 2026-03-05 |
|
Perl Jessica
SVP, General Counsel, Corp Sec
|
— | — | 2026-03-05 |
|
Lowry Simon C
SVP, R&D, CMO
|
— | — | 2026-03-05 |